Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Payer partnerships and pharmacy-bundled models are included when they support a licensed care pathway
Retatrutide influences metabolic pathways and appetite through its coordinated activation of the GLP-1, GIP, and glucagon receptors
It has been shown to improve insulin sensitivity, reduce obesity, and prevent diet-induced insulin resistance
Brand-name semaglutide includes FDA-approved drugs like Ozempic (approved for type 2 diabetes), Wegovy (approved for chronic weight management), and Rybelsus (an oral option for diabetes)
US$ 23.73
US$ 20.69
US$ 20.69
US$ 27.14
US$ 29.64
